<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Long-term follow-up data are presented on changes in peripheral blood counts and Hb requirements of 11 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) during iron chelation treatment with <z:chebi fb="0" ids="4356">desferrioxamine</z:chebi> for up to 60 months </plain></SENT>
<SENT sid="1" pm="."><plain>The erythroid marrow activity was indirectly evaluated by repeated determinations of the serum transferrin receptor concentration </plain></SENT>
<SENT sid="2" pm="."><plain>The efficacy of iron chelation was evaluated by repeated quantitative determination of the liver iron concentration by magnetic resonance imaging </plain></SENT>
<SENT sid="3" pm="."><plain>Reduction in the Hb requirement ( &gt; or = 50%) was seen in 7/11 (64%) patients </plain></SENT>
<SENT sid="4" pm="."><plain>Five patients (46%) became blood transfusion independent </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">Platelet counts increased</z:e> in 7/11 (64%) patients and the neutrophil counts in 7/9 (78%) evaluable patients </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients in whom iron chelation was highly effective showed improvement of erythropoietic output accompanied by an increase in the serum transferrin receptor concentration </plain></SENT>
<SENT sid="7" pm="."><plain>It is concluded that reduction in cytopenia in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients may be accomplished by treatment with <z:chebi fb="0" ids="4356">desferrioxamine</z:chebi>, if the iron chelation is efficient and the patients are treated for a sufficiently long period of time </plain></SENT>
<SENT sid="8" pm="."><plain>Exactly how treatment with <z:chebi fb="0" ids="4356">desferrioxamine</z:chebi> works remains a challenge for further investigation </plain></SENT>
</text></document>